Zmapp Approval Conclusive Consequent Certain. Web zmapp was a cocktail of monoclonal antibodies, the first to be suggested 2 years earlier as a potential. Web the palm trial enrolled patients with confirmed ebola infection for treatment with inmazeb, another.

Web the palm trial enrolled patients with confirmed ebola infection for treatment with inmazeb, another. Food and drug administration approved inmazeb (atoltivimab, maftivimab, and odesivimab. Web today, the u.s.